N (%) | Nonideators | Ideators | P |
---|---|---|---|
147,575 (96.50) | 7,348 (3.50) | ||
Age group | <.001 | ||
21–25 years | 9.25 | 15.75 | |
26–34 years | 16.70 | 19.21 | |
35–49 years | 28.80 | 33.38 | |
50–64 years | 26.78 | 23.05 | |
65+ years | 18.47 | 8.61 | |
Male | 48.07 | 46.69 | .151 |
Race/ethnicity | <.001 | ||
Non-Hispanic White | 68.04 | 73.55 | |
Black | 11.38 | 10.52 | |
Hispanic | 13.90 | 9.46 | |
Asian | 4.70 | 3.38 | |
Other | 1.98 | 3.08 | |
Not married | 42.66 | 60.99 | <.001 |
Education | <.001 | ||
<High school (HS) | 14.25 | 14.62 | |
HS graduate | 29.64 | 31.0 | |
Some college | 25.25 | 29.33 | |
College graduate | 30.86 | 25.05 | |
Not employed | 34.35 | 42.67 | <.001 |
Income <200% FPLa | 31.55 | 43.46 | <.001 |
Military service | 11.38 | 11.17 | .776 |
Health insurance coverage gap | 5.04 | 9.31 | <.001 |
Major depressive episode | 5.10 | 46.97 | <.001 |
Substance use disorders (SUD) | 7.75 | 25.71 | <.001 |
Alcohol abuse/dependence | 6.44 | 20.41 | <.001 |
Illicit drug abuse/dependence | 1.85 | 10.71 | <.001 |
Any substance abuse treatment use | 1.39 | 7.78 | <.001 |
Among those with SUD | 9.23 | 21.46 | <.001 |
Professional MHb treatment use | 12.61 | 50.01 | <.001 |
Inpatient | 0.52 | 8.17 | <.001 |
Outpatient | 5.82 | 32.36 | <.001 |
Pharmacotherapy | 10.65 | 44.57 | <.001 |
Alternative MH treatment use | 8.32 | 22.49 | <.001 |
Any MH (professional and/or alternative) treatment use | 17.89 | 55.93 | <.001 |
Perceived MH treatment need | 3.61 | 35.13 | <.001 |
Without any treatment | 2.10 | 24.49 | <.001 |
With any treatment | 14.09 | 45.76 | <.001 |